Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoantibodies and interstitial cystitis

R L Ochs1

  • 1W. M. Keck Autoimmune Disease Center, Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, California, USA.

Clinics in Laboratory Medicine
|October 8, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differential in vitro effects of chemotherapeutic agents on primary cultures of human ovarian carcinoma.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2004
Same author

Nucleolar ultrastructure and protein allocation in in vitro produced porcine embryos.

Molecular reproduction and development·2004
Same author

Nucleolar proteins and ultrastructure in bovine in vivo developed, in vitro produced, and parthenogenetic cleavage-stage embryos.

Molecular reproduction and development·2003
Same author

Nucleolar protein allocation and ultrastructure in bovine embryos produced by nuclear transfer from embryonic cells.

Cloning·2002
Same author

Nucleolar protein allocation and ultrastructure in bovine embryos produced by nuclear transfer from granulosa cells.

Molecular reproduction and development·2002
Same author

Nuclear apoptotic changes: an overview.

Journal of cellular biochemistry·2001
Same journal

Advances in Hemostasis Laboratory Testing.

Clinics in laboratory medicine·2026
Same journal

Extracellular Vesicles in Hemostasis.

Clinics in laboratory medicine·2026
Same journal

Thrombin Generation Assay: Ready for Prime Time.

Clinics in laboratory medicine·2026
Same journal

Viscoelastic Testing for the Laboratorian: Recent Advances and Practical Advice.

Clinics in laboratory medicine·2026
Same journal

Practical Recommendations for Harmonization of Hemostasis Testing Across Hospital Sites.

Clinics in laboratory medicine·2026
Same journal

The Role of Hypoxia in Vascular Endothelial Dysfunction and Venous Thromboembolism.

Clinics in laboratory medicine·2026
See all related articles

Interstitial cystitis (IC), a chronic bladder condition, may involve autoimmune factors. Research indicates up to 50% of IC patients have autoantibodies, prompting further investigation into their diagnostic and therapeutic potential.

Area of Science:

  • Urology and Immunology
  • Investigating the intersection of autoimmune responses and bladder inflammation.

Background:

  • Interstitial cystitis (IC) is a chronic bladder condition causing pain, urgency, and frequency.
  • The exact cause of IC remains unknown, but autoimmune mechanisms are suspected.
  • Previous findings suggest a significant portion of IC patients possess autoantibodies.

Purpose of the Study:

  • To explore the potential role of autoantibody testing in the diagnosis of IC.
  • To assess the relationship between autoantibodies and the prognosis of IC.
  • To investigate the utility of autoantibodies in guiding therapy for IC patients.

Main Methods:

  • Analysis of autoantibody presence in a cohort of interstitial cystitis patients.
  • Characterization of identified autoantibodies, noting novel and shared specificities.

Related Experiment Videos

  • Correlation of autoantibody profiles with clinical data including diagnosis, prognosis, and treatment response.

    • Main Results:

    • Up to 50% of patients with interstitial cystitis exhibit detectable autoantibodies.
    • Identified autoantibodies include both novel specificities and those associated with other autoimmune diseases.
    • Preliminary data suggests a potential link between autoantibody presence and IC characteristics.

    Conclusions:

    • Autoimmune mechanisms, indicated by autoantibody presence, are likely implicated in IC pathogenesis.
    • Autoantibody testing may offer a valuable tool for diagnosing and understanding IC.
    • Further research is warranted to establish autoantibodies as biomarkers for IC prognosis and therapeutic targets.